Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content; the detailed study information and related sections appear to be removed or inaccessible, and the standard site footer is shown.SummaryDifference17%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.6.6 is now shown, replacing the previous v3.6.5. This indicates a small update to the study record’s versioning rather than a modification to the study data or participant information.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays a 500 error/An error occurred message, replacing the study record content with an unavailable-page notice. The previous study details, navigation, and related data are no longer visible on the page.SummaryDifference16%

- Check54 days agoChange DetectedNo changes are recorded in the provided data. The page content remains as listed in the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision tag, Revision: v3.6.4, appears on the page to indicate a version update of the study page. The previous Revision: v3.6.3 tag is removed, reflecting the updated version.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision label was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a recent update to the ClinicalTrials.gov entry.SummaryDifference0.1%

Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.